In vivo treatment ofHelicobacter pyloriinfection with liposomal linolenic acid reduces colonization and ameliorates inflammation
出版年份 2014 全文链接
标题
In vivo treatment ofHelicobacter pyloriinfection with liposomal linolenic acid reduces colonization and ameliorates inflammation
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 49, Pages 17600-17605
出版商
Proceedings of the National Academy of Sciences
发表日期
2014-11-25
DOI
10.1073/pnas.1418230111
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery
- (2014) Weiwei Gao et al. ACS Nano
- Treatment ofHelicobacter pyloriInfection 2013
- (2013) Anthony O'Connor et al. HELICOBACTER
- Deficiency of the Myeloid Differentiation Primary Response Molecule MyD88 Leads to an Early and Rapid Development of Helicobacter-Induced Gastric Malignancy
- (2013) Anirban Banerjee et al. INFECTION AND IMMUNITY
- Understanding biocatalyst inhibition by carboxylic acids
- (2013) Laura R. Jarboe et al. Frontiers in Microbiology
- Liposome-like nanostructures for drug delivery
- (2013) Weiwei Gao et al. Journal of Materials Chemistry B
- Antibacterial Activities of Liposomal Linolenic Acids against Antibiotic-Resistant Helicobacter pylori
- (2012) Marygorret Obonyo et al. MOLECULAR PHARMACEUTICS
- A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
- (2012) E. A. Nance et al. Science Translational Medicine
- Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis
- (2011) Undurti N. Das CANCER AND METASTASIS REVIEWS
- Effects of Myeloid Differentiation Primary Response Gene 88 (MyD88) Activation on Helicobacter Infection In Vivo and Induction of a Th17 Response
- (2011) Marygorret Obonyo et al. HELICOBACTER
- A Comparative Evaluation of Mono-, Di- and Triglyceride of Medium Chain Fatty Acids by Lipid/Surfactant/Water Phase Diagram, Solubility Determination and Dispersion Testing for Application in Pharmaceutical Dosage Form Development
- (2011) Hetal N. Prajapati et al. PHARMACEUTICAL RESEARCH
- Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids
- (2010) Chun-Ming Huang et al. BIOMATERIALS
- Development of Nanoparticles for Antimicrobial Drug Delivery
- (2010) L. Zhang et al. CURRENT MEDICINAL CHEMISTRY
- Helicobacter pyloriInfection
- (2010) Kenneth E.L. McColl NEW ENGLAND JOURNAL OF MEDICINE
- A Redox Basis for Metronidazole Resistance in Helicobacter pylori
- (2009) N. O. Kaakoush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential
- (2009) Andrew P. Desbois et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy
- (2009) Yu-Hsin Lin et al. BIOMATERIALS
- The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes
- (2009) Darren Yang et al. BIOMATERIALS
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
- (2008) Samuel K. Lai et al. ADVANCED DRUG DELIVERY REVIEWS
- Triple therapy-based targeted nanoparticles for the treatment ofHelicobacter pylori
- (2008) Suman Ramteke et al. JOURNAL OF DRUG TARGETING
- Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment ofHelicobacter pylori
- (2008) Suman Ramteke et al. JOURNAL OF DRUG TARGETING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started